Revenue
$0
▼ 100.0% YoY
Net Income
-$83.9M
▼ 28.3% YoY
EPS
$-3.43
▲ 41.0% YoY
Cash
$26.7M
▼ 33.6% YoY
FY 2025 · As of 2025-12-31
Last 90 days
| Insider | Type | Date | Shares | Price | Value | |
|---|---|---|---|---|---|---|
RA CAPITAL MANAGEMENT, L.P. | Buy | Jun 16, 2026 | 124.9K | $8.89 | $1.11M | Form 4 ↗ |
RA CAPITAL MANAGEMENT, L.P. | Buy | Jun 15, 2026 | 15.4K | $8.99 | $139K | Form 4 ↗ |
RA CAPITAL MANAGEMENT, L.P. | Buy | Jun 12, 2026 | 391.0K | $8.57 | $3.35M | Form 4 ↗ |
RA CAPITAL MANAGEMENT, L.P. | Buy | Jun 11, 2026 | 548.6K | $7.91 | $4.34M | Form 4 ↗ |
RA CAPITAL MANAGEMENT, L.P. | Buy | Jun 10, 2026 | 103 | $7.00 | $721 | Form 4 ↗ |
RA CAPITAL MANAGEMENT, L.P. | Buy | Jun 9, 2026 | 479.0K | $6.91 | $3.31M | Form 4 ↗ |
Raymon Heather SVP, Research and Development | Sell | May 19, 2026 | 3.1K | $9.01 | $28K | Form 4 ↗ |
Horan Christopher Chief Tech Operations Officer | Sell | May 19, 2026 | 7.0K | $9.01 | $63K | Form 4 ↗ |
Bush Jennifer COO, CLO, Compliance Officer | Sell | May 19, 2026 | 8.8K | $9.01 | $79K | Form 4 ↗ |
Banerjee Subhashis Chief Medical Officer | Sell | May 19, 2026 | 7.0K | $9.01 | $63K | Form 4 ↗ |
Aslan Fred Chief Executive Officer | Sell | May 19, 2026 | 27.1K | $9.01 | $244K | Form 4 ↗ |
Miralles Gines Diego President & Head of R&D | Grant | May 18, 2026 | 77.5K | $0.00 | $0 | Form 4 ↗ |
GC Corp. | Buy | May 11, 2026 | 1.09M | $11.52 | $12.50M | Form 4 ↗ |
GC Corp. | Buy | May 11, 2026 | 347.2K | $11.52 | $4.00M | Form 4 ↗ |
RA CAPITAL MANAGEMENT, L.P. | Buy | May 11, 2026 | 6.51M | $11.52 | $75.00M | Form 4 ↗ |